Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	62.07B
Revenue (ttm)	19.07B
Net Income (ttm)	2.14B
Shares Out	1.59B
EPS (ttm)	1.34
PE Ratio	29.04
Forward PE	17.75
Dividend	1.01 (2.47%)
Ex-Dividend Date	Jun 13, 2025

Volume	8,295,500
Average Volume	18,561,889
Open	35.99
Previous Close	39.02
Day's Range	35.99 - 39.99
52-Week Range	25.72 - 41.72
Beta	-0.10
RSI	65.66
Earnings Date	Aug 29, 2025

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion set, dispensing and injection syringes, detained needles, nebulizer, and vacuum blood collection tubes; over-the-counter products; and APIs for treatment of cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD an...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 21,864
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.